These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11815499)

  • 1. Obesity and treatment of diabetes with glyburide may both be risk factors for acute pancreatitis.
    Blomgren KB; Sundström A; Steineck G; Wiholm BE
    Diabetes Care; 2002 Feb; 25(2):298-302. PubMed ID: 11815499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: A population-based case-control study in Taiwan.
    Liao KF; Lin CL; Lai SW; Chen WC
    Eur J Intern Med; 2016 Jan; 27():76-9. PubMed ID: 26433909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incretin therapies and risk of hospital admission for acute pancreatitis in an unselected population of European patients with type 2 diabetes: a case-control study.
    Giorda CB; Picariello R; Nada E; Tartaglino B; Marafetti L; Costa G; Gnavi R
    Lancet Diabetes Endocrinol; 2014 Feb; 2(2):111-5. PubMed ID: 24622714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Swedish case-control network for studies of drug-induced morbidity--acute pancreatitis.
    Blomgren KB; Sundström A; Steineck G; Genell S; Sjöstedt S; Wiholm BE
    Eur J Clin Pharmacol; 2002 Jul; 58(4):275-83. PubMed ID: 12136374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute pancreatitis in association with type 2 diabetes and antidiabetic drugs: a population-based cohort study.
    Gonzalez-Perez A; Schlienger RG; Rodríguez LA
    Diabetes Care; 2010 Dec; 33(12):2580-5. PubMed ID: 20833867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study.
    Knapen LM; de Jong RG; Driessen JH; Keulemans YC; van Erp NP; De Bruin ML; Leufkens HG; Croes S; de Vries F
    Diabetes Obes Metab; 2017 Mar; 19(3):401-411. PubMed ID: 27883260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incretin-based drugs and risk of acute pancreatitis: A nested-case control study within a healthcare database.
    Soranna D; Bosetti C; Casula M; Tragni E; Catapano AL; Vecchia CL; Merlino L; Corrao G
    Diabetes Res Clin Pract; 2015 May; 108(2):243-9. PubMed ID: 25748827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: a nested case-control study.
    Abdelmoneim AS; Eurich DT; Gamble JM; Johnson JA; Seubert JM; Qiu W; Simpson SH
    Diabetes Obes Metab; 2014 Jan; 16(1):22-9. PubMed ID: 23802997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease and risk of acute pancreatitis in a population-based study.
    Bexelius TS; Ljung R; Mattsson F; Lagergren J
    Pancreas; 2013 Aug; 42(6):1011-5. PubMed ID: 23851434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incretin-based therapy and risk of acute pancreatitis: a nationwide population-based case-control study.
    Thomsen RW; Pedersen L; Møller N; Kahlert J; Beck-Nielsen H; Sørensen HT
    Diabetes Care; 2015 Jun; 38(6):1089-98. PubMed ID: 25633664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative cardiovascular safety of insulin secretagogues following hospitalization for ischemic heart disease among type 2 diabetes patients: a cohort study.
    Huang Y; Abdelmoneim AS; Light P; Qiu W; Simpson SH
    J Diabetes Complications; 2015 Mar; 29(2):196-202. PubMed ID: 25534984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II receptor blockers and risk of acute pancreatitis - a population based case-control study in Sweden.
    Bexelius TS; Ljung R; Mattsson F; Lu Y; Lindblad M
    BMC Gastroenterol; 2017 Mar; 17(1):36. PubMed ID: 28270103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid-suppressing drugs and gastroesophageal reflux disease as risk factors for acute pancreatitis--results from a Swedish Case-Control Study.
    Sundström A; Blomgren K; Alfredsson L; Wiholm BE
    Pharmacoepidemiol Drug Saf; 2006 Mar; 15(3):141-9. PubMed ID: 16200654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of acute pancreatitis in type 2 diabetes and risk reduction on anti-diabetic drugs: a population-based cohort study in Taiwan.
    Lai SW; Muo CH; Liao KF; Sung FC; Chen PC
    Am J Gastroenterol; 2011 Sep; 106(9):1697-704. PubMed ID: 21577242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control study.
    Sadr-Azodi O; Mattsson F; Bexlius TS; Lindblad M; Lagergren J; Ljung R
    JAMA Intern Med; 2013 Mar; 173(6):444-9. PubMed ID: 23440105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: a population-based nested case-control study.
    Weir MA; Gomes T; Mamdani M; Juurlink DN; Hackam DG; Mahon JL; Jain AK; Garg AX
    Nephrol Dial Transplant; 2011 Jun; 26(6):1888-94. PubMed ID: 20974644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National trends in incidence and outcomes of acute pancreatitis among type 2 diabetics and non-diabetics in Spain (2001-2011).
    Méndez-Bailón M; de Miguel Yanes JM; Jiménez-García R; Hernández-Barrera V; Pérez-Farinós N; López-de-Andrés A
    Pancreatology; 2015; 15(1):64-70. PubMed ID: 25500341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes.
    Tuccori M; Wu JW; Yin H; Majdan A; Azoulay L
    Diabetes Care; 2015 Nov; 38(11):2083-9. PubMed ID: 26341130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sitagliptin increases acute pancreatitis risk within 2 years of its initiation: A retrospective cohort analysis of the National Health Insurance database in Taiwan.
    Tseng CH
    Ann Med; 2015; 47(7):561-9. PubMed ID: 26426676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypharmacy and risk of acute pancreatitis.
    Razavi D; Lindblad M; Bexelius T; Oskarsson V; Sadr-Azodi O; Ljung R
    Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1337-1341. PubMed ID: 27651204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.